Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bruker (BRKRP) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Bruker (BRKRP) over the last 16 years, with Q4 2024 value amounting to $187.8 million.

  • Bruker's Accumulated Expenses rose 1279.28% to $187.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $187.8 million, marking a year-over-year increase of 1279.28%. This contributed to the annual value of $187.8 million for FY2024, which is 1279.28% up from last year.
  • Latest data reveals that Bruker reported Accumulated Expenses of $187.8 million as of Q4 2024, which was up 1279.28% from $166.5 million recorded in Q4 2023.
  • In the past 5 years, Bruker's Accumulated Expenses registered a high of $187.8 million during Q4 2024, and its lowest value of $110.6 million during Q4 2020.
  • In the last 5 years, Bruker's Accumulated Expenses had a median value of $136.1 million in 2022 and averaged $146.6 million.
  • As far as peak fluctuations go, Bruker's Accumulated Expenses surged by 310.61% in 2022, and later surged by 2233.65% in 2023.
  • Quarter analysis of 5 years shows Bruker's Accumulated Expenses stood at $110.6 million in 2020, then increased by 19.35% to $132.0 million in 2021, then grew by 3.11% to $136.1 million in 2022, then rose by 22.34% to $166.5 million in 2023, then increased by 12.79% to $187.8 million in 2024.
  • Its Accumulated Expenses stands at $187.8 million for Q4 2024, versus $166.5 million for Q4 2023 and $136.1 million for Q4 2022.